Narrative Review: Pharmacotherapy for Chronic Heart Failure: Evidence from Recent Clinical Trials

2005 ◽  
Vol 142 (2) ◽  
pp. 132 ◽  
Author(s):  
Andrew T. Yan ◽  
Raymond T. Yan ◽  
Peter P. Liu
Keyword(s):  
Heart Failure ◽  
Clinical Trials ◽  
Chronic Heart Failure ◽  
Narrative Review

scholarly journals Clinical Characteristics of De Novo Heart Failure and Acute Decompensated Chronic Heart Failure: Are They Distinctive Phenotypes That Contribute to Different Outcomes?

2021 ◽  
Vol 7 ◽  
Author(s):  
Wilson Matthew Raffaello ◽  
Joshua Henrina ◽  
Ian Huang ◽  
Michael Anthonius Lim ◽  
Leonardo Paskah Suciadi ◽  
...  
Keyword(s):  
Heart Failure ◽  
Clinical Trials ◽  
Chronic Heart Failure ◽  
Poor Prognosis ◽  
Clinical Characteristics ◽  
De Novo ◽  
Heart Failure Patients ◽  
Treat Heart Failure ◽  
Patients With Heart Failure ◽  
New Strategies

Heart failure is currently one of the leading causes of morbidity and mortality. Patients with heart failure often present with acute symptoms and may have a poor prognosis. Recent evidence shows differences in clinical characteristics and outcomes between de novo heart failure (DNHF) and acute decompensated chronic heart failure (ADCHF). Based on a better understanding of the distinct pathophysiology of these two conditions, new strategies may be considered to treat heart failure patients and improve outcomes. In this review, the authors elaborate distinctions regarding the clinical characteristics and outcomes of DNHF and ADCHF and their respective pathophysiology. Future clinical trials of therapies should address the potentially different phenotypes between DNHF and ADCHF if meaningful discoveries are to be made.

scholarly journals Erratum to: Beta-Blockers and Ivabradine in Chronic Heart Failure: From Clinical Trials to Clinical Practice

2014 ◽  
Vol 14 (4) ◽  
pp. 333-333
Author(s):  
Antonino Di Franco ◽  
Filippo M. Sarullo ◽  
Ylenia Salerno ◽  
Stefano Figliozzi ◽  
Rossella Parrinello ◽  
...  
Keyword(s):  
Heart Failure ◽  
Clinical Trials ◽  
Clinical Practice ◽  
Chronic Heart Failure ◽  
Beta Blockers

Recognizing Worsening Chronic Heart Failure as an Entity and an End Point in Clinical Trials

JAMA ◽  
2014 ◽  
Vol 312 (8) ◽  
pp. 789 ◽  
Author(s):  
Javed Butler ◽  
Eugene Braunwald ◽  
Mihai Gheorghiade
Keyword(s):  
Heart Failure ◽  
Clinical Trials ◽  
Chronic Heart Failure ◽  
End Point

scholarly journals Contemporary therapies for chronic heart failure with reduced ejection fraction

2020 ◽  
pp. 146-151
Author(s):  
E Klug ◽  
N Tsabedze
Keyword(s):  
Heart Failure ◽  
Chronic Heart Failure ◽  
Ejection Fraction ◽  
Medical Therapy ◽  
Medical Management ◽  
Narrative Review ◽  
Reduced Ejection Fraction

Heart failure with reduced ejection fraction (HFrEF) is common, and without optimal guideline-mandated medical therapy, is disabling and fatal. As trials discover effective additional HFrEF therapies, it is essential that all healthcare practitioners develop competence in treating these patients optimally. This narrative review discusses the approach to the contemporary medical management of HFrEF.

Sign in / Sign up

Export Citation Format

Share Document